Literature DB >> 358722

Prostaglandin-stimulated gastric mucus secretion in man.

W Domschke, S Domschke, D Hornig, L Demling.   

Abstract

In 6 healthy volunteers, following intragastric instillation of a prostaglandin analogue pentagastrinstimulated gastric secretion of acid, pepsin, and glycoprotein N-acetylneuraminic acid (NANA) was assessed. There was only a slight and statistically insignificant inhibition of acid output while pepsin secretion remained entirely unaffected. On the other hand, gastric mucus (NANA) secretion was significantly increased dependent on the prostaglandin dose administered. It is concluded that prostaglandins in addition to their well-known gastric acid inhibitory action may exert mucus stimulating properties and thus may have a direct protective effect on the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 358722

Source DB:  PubMed          Journal:  Acta Hepatogastroenterol (Stuttg)        ISSN: 0300-970X


  8 in total

1.  Misoprostol-induced increases in adherent gastric mucus thickness and luminal mucus output.

Authors:  L A Sellers; N J Carroll; A Allen
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

Review 2.  Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection.

Authors:  A Allen; A Garner
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

3.  Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?

Authors:  P Dandona; J Y Jeremy
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Diclofenac delays healing of gastroduodenal mucosal lesions. Double-blind, placebo-controlled endoscopic study in healthy volunteers.

Authors:  P Stadler; D Armstrong; D Margalith; E Saraga; M Stolte; P Lualdi; G Mautone; A L Blum
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

Review 5.  Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.

Authors:  J P Monk; S P Clissold
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

6.  The effects of a prostaglandin endoperoxide analogue on canine gastric acid and mucus secretion.

Authors:  P Tao; W Scruggs; D E Wilson
Journal:  Dig Dis Sci       Date:  1979-06       Impact factor: 3.199

7.  Gallbladder mucosal protein secretion during development of experimental cholecystitis.

Authors:  D L Kaminski; Y G Deshpande; A Li; F Dysart; M Nag
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

8.  Adherent and soluble mucus in the stomach and duodenum.

Authors:  A Allen; N J Carroll
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.